These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 7746038)

  • 1. [A breakthrough for research on Alzheimer disease. A model for drug testing].
    Nordstedt C; Näslund J; Tjernberg LO; Terenius L
    Lakartidningen; 1995 May; 92(18):1899-900. PubMed ID: 7746038
    [No Abstract]   [Full Text] [Related]  

  • 2. Alzheimer research forum live discussion: mice on trial? Issues in the design of drug studies.
    J Alzheimers Dis; 2009; 16(1):197-205. PubMed ID: 19158436
    [No Abstract]   [Full Text] [Related]  

  • 3. A small molecule targeting the multifactorial nature of Alzheimer's disease.
    Cavalli A; Bolognesi ML; Capsoni S; Andrisano V; Bartolini M; Margotti E; Cattaneo A; Recanatini M; Melchiorre C
    Angew Chem Int Ed Engl; 2007; 46(20):3689-92. PubMed ID: 17397121
    [No Abstract]   [Full Text] [Related]  

  • 4. Neurologists strike gold in drug screen effort.
    Abbott A
    Nature; 2002 May; 417(6885):109. PubMed ID: 12000928
    [No Abstract]   [Full Text] [Related]  

  • 5. Powerful beneficial effects of macrophage colony-stimulating factor on beta-amyloid deposition and cognitive impairment in Alzheimer's disease.
    Boissonneault V; Filali M; Lessard M; Relton J; Wong G; Rivest S
    Brain; 2009 Apr; 132(Pt 4):1078-92. PubMed ID: 19151372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transgenic model applications to drug discovery.
    Polites HG
    Int J Exp Pathol; 1996 Dec; 77(6):257-62. PubMed ID: 9155659
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibitors of the CDC25 phosphatases.
    Prevost GP; Brezak MC; Goubin F; Mondesert O; Galcera MO; Quaranta M; Alby F; Lavergne O; Ducommun B
    Prog Cell Cycle Res; 2003; 5():225-34. PubMed ID: 14593717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A strategy for identifying immunosuppressive therapies for Alzheimer disease.
    Giulian D
    Alzheimer Dis Assoc Disord; 1998; 12 Suppl 2():S7-14. PubMed ID: 9769024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 12th international conference on Alzheimer's disease. Part 1. 11-16 July 2009, Vienna, Austria.
    Filson S
    IDrugs; 2009 Sep; 12(9):535-6. PubMed ID: 19697267
    [No Abstract]   [Full Text] [Related]  

  • 10. Design and development of BACE-1 inhibitors.
    Cumming JN; Iserloh U; Kennedy ME
    Curr Opin Drug Discov Devel; 2004 Jul; 7(4):536-56. PubMed ID: 15338962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapeutic strategies and Alzheimer's disease: contribution of animal models].
    Chabrier PE
    Ann Pharm Fr; 2009 Mar; 67(2):97-103. PubMed ID: 19298893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Commentary on "a roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Alzheimer's disease translational research programs at the National Institute on Aging.
    Petanceska S; Ryan L; Silverberg N; Buckholtz N
    Alzheimers Dement; 2009 Mar; 5(2):130-2. PubMed ID: 19328442
    [No Abstract]   [Full Text] [Related]  

  • 13. [Don't underestimate the value of transgenic animal models of Alzheimer disease].
    Nilsson LN; Lannfelt L; Basun H; Nordberg A; Winblad B
    Lakartidningen; 2007 Mar 7-13; 104(10):798-9; discussion 799-800. PubMed ID: 17432800
    [No Abstract]   [Full Text] [Related]  

  • 14. 12th international conference on Alzheimer's disease. Part 2. 11-16 July 2009, Vienna, Austria.
    Filson S
    IDrugs; 2009 Sep; 12(9):537-8. PubMed ID: 19697268
    [No Abstract]   [Full Text] [Related]  

  • 15. [Development of donepezil hydrochloride (Aricept) for the treatment of Alzheimer's disease].
    Yamanishi Y; Ogura H; Kosasa T
    Tanpakushitsu Kakusan Koso; 2000 Apr; 45(6 Suppl):1047-51. PubMed ID: 10771671
    [No Abstract]   [Full Text] [Related]  

  • 16. Saving the mind faces high hurdles.
    Travis J
    Science; 2005 Jul; 309(5735):731. PubMed ID: 16051787
    [No Abstract]   [Full Text] [Related]  

  • 17. Guidelines for the preclinical in vivo evaluation of pharmacological active drugs for ALS/MND: report on the 142nd ENMC international workshop.
    Ludolph AC; Bendotti C; Blaugrund E; Hengerer B; Löffler JP; Martin J; Meininger V; Meyer T; Moussaoui S; Robberecht W; Scott S; Silani V; Van Den Berg LH;
    Amyotroph Lateral Scler; 2007 Aug; 8(4):217-23. PubMed ID: 17653919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Alzheimer's disease: a breakthrough in research?].
    Krankenpfl J; 1999 Sep; 37(9):339. PubMed ID: 10542567
    [No Abstract]   [Full Text] [Related]  

  • 19. Reducing brain inflammation with novel class of drug.
    Purslow C
    Expert Rev Clin Pharmacol; 2012 Sep; 5(5):498. PubMed ID: 23272329
    [No Abstract]   [Full Text] [Related]  

  • 20. Preclinical models of arthritic disease in non-human primates.
    Vierboom MP; Jonker M; Tak PP; 't Hart BA
    Drug Discov Today; 2007 Apr; 12(7-8):327-35. PubMed ID: 17395093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.